A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients

NCT00001504 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

NIH

Sponsor class

Conditions

Breast Cancer
Breast Neoplasm

Interventions

DRUG: 9-cis-Retinoic Acid

Sponsor

National Cancer Institute (NCI)